BLSM SCHEDULE 13G: SEC filing

Vivo Innovation Fund II Holdings, L.P. and Vivo Innovation II, LLC

Filed with the SEC on · accession 0001213900-26-090726

BLSM filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 17, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +1.2% by the first close after the filing.

Summary of the filing

Vivo Innovation Fund II Holdings, L.P. and Vivo Innovation II, LLC filed a Schedule 13G joint filing agreement regarding their beneficial ownership position in BlossomHill Therapeutics, Inc. The filing indicates a passive investment stake held by the Vivo entities.

Key details

Filer / beneficial ownerVivo Innovation Fund II Holdings, L.P.
Filer / general partnerVivo Innovation II, LLC
Issuer / subject companyBlossomHill Therapeutics, Inc.
Managing member of vivo innovation ii, llc, general partnerGaurav Aggarwal

How BLSM stock reacted

Close before

$16.18

Aug 14, 2026

First close after

+1.24%

$16.38

5 trading days

+1.24%

$16.38

Since filing

-16.56%

$13.50

✦ Ask GOAX AI about this filing — what it means for BLSM, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BLSM?

Click here

Frequently asked questions

What did BLSM file with the SEC on Aug 17, 2026?

BLSM filed a SCHEDULE 13G (SEC filing). Vivo Innovation Fund II Holdings, L.P. and Vivo Innovation II, LLC filed a Schedule 13G joint filing agreement regarding their beneficial ownership position in BlossomHill Therapeutics, Inc. The filing indicates a passive investment stake held by the Vivo entities.

How do I read a SCHEDULE 13G?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).

How did BLSM stock react to this filing?

BLSM closed at $16.18 before the filing and $16.38 on Aug 17, 2026 (+1.24%). Five trading days later: $16.38 (+1.24%).

Other BLSM SEC filings

Get alerts when BLSM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days